Abstract
Few dermatologic problems carry as much emotional overtones as the complaint of hair loss. Adding to some patient’s worry may be prior frustrating experiences with physicians, who tend to trivialize complaints of hair loss or dismiss them completely. This attitude on the part of physicians is related either to lack of comprehension of the impact of hair loss on quality of life or to lack of confidence in the treatment of alopecia.
Treatment options are available, though limited, both in terms of indications and of efficacy. Success depends not only on comprehension of the underlying pathology but also on unpatronizing sympathy from the part of the physician.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsFurther Reading
Evidence-Based Medicine
Rawson E (1982) The life and death of asclepiades of bithynia. Class Q 32:358–370
Listening to the Patient
Cash TF (1992) The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 26:926–931
Cash TF (1999) The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol 141:398–405
Maffei C, Fossati A, Rinaldi F, Riva E (1994) Personality disorders and psychopathologic symptoms in patients with androgenetic alopecia. Arch Dermatol 130:868–872
Neumann M, Scheffer C, Tauschel D, Lutz G, Wirtz M, Edelhäuser F (2012) Physician empathy: definition, outcome-relevance and its measurement in patient care and medical education. GMS Z Med Ausbild 29:Doc11
Teutsch C (2003) Patient-doctor communication. Med Clin North Am 87:1115–1145
Yamazaki M, Miyakura T, Uchiyama M, Hobo A, Irisawa R, Tsuboi R (2011) Oral finasteride improved the quality of life of androgenetic alopecia patients. J Dermatol 38:773–777
Tackling Side Effects
Altomare G, Capella GL (2002) Depression circumstantially related to the administration of finasteride for androgenetic alopecia. J Dermatol 29:665–669
Baibergenova A, Walsh S (2012) Use of pioglitazone in patients with lichen planopilaris. J Cutan Med Surg 16:97–100
Finn DA, Long SL, Tanchuck MA, Crabbe J (2004) Interaction of chronic ethanol exposure and finasteride: sex and strain differences. Pharmacol Biochem Behav 78:435–443
Georgala S, Befon A, Maniatopoulou E, Georgala C (2007) Topical use of minoxidil in children and systemic side effects. Dermatology 214:101–102
Glina S, Neves PA, Saade R, Netto NR Jr, Soares JB, Galuppo AG (2004) Finasteride-associated male infertility. Rev Hosp Clin Fac Med Sao Paulo 59:203–205
Gorin RE, Crabbe JC, Tanchuck MA, Long SL, Finn DA (2005) Effects of finasteride on chronic and acute ethanol withdrawal severity in the WSP and WSR selected lines. Alcohol Clin Exp Res 29:939–948
Hepp U, Kraemer B, Schnyder U, Miller N, Delsignore A (2005) Psychiatric comorbidity in gender identity disorder. J Psychosom Res 58:259–261
Irwig MS (2012) Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects. J Clin Psychiatry 73:1220–1223
Irwig MS (2013) Decreased alcohol consumption among former male users of finasteride with persistent sexual side effects: a preliminary report. Alcohol Clin Exp Res doi:10.1111/acer.12177. [Epub ahead of print]
Irwig MS, Kolukula S (2011) Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med 8:1747–1753
Mirmirani P, Karnik P (2009) Lichen planopilaris treated with a peroxisome proliferator-activated receptor gamma agonist. Arch Dermatol 145:1363–1366
Morrow J (1999) New profits in old bottles; companies find bonus in drugs that cure several ills. The New York Times, 19 March
Overstreet JW, Fuh VL, Gould J, Howards SS, Lieber MM, Hellstrom W, Shapiro S, Carroll P, Corfman RS, Petrou S, Lewis R, Toth P, Shown T, Roy J, Jarow JP, Bonilla J, Jacobsen CA, Wang DZ, Kaufman KD (1999) Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol 162:1295–1300
Ramot Y, Czarnowicki T, Zlotogorski A (2009) Finasteride induced gynecomastia: case report and review of the Literature. Int J Trichol 1:27–29
Ricci G, Martinelli M, Luppi S, Lo Bello L, De Santis M, Skerk K, Zito G (2012) Finasteride and fertility: case report and review of the literature. J Drugs Dermatol 11:1511–1513
Rossi A, Cantisani C, Scarnò M, Trucchia A, Fortuna MC, Calvieri S (2011) Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up. Dermatol Ther 24:455–461
Sandomir R (2006) Skin deep; fighting baldness, and now an olympic ban. The New York Times, 19 January
Sato A, Takeda A (2012) Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia. J Dermatol 39:27–32
Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA Jr (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349:215–224
Thompson IM Jr, Goodman PJ, Tangen CM, Parnes HL, Minasian LM, Godley PA, Lucia MS, Ford LG (2013) Long-term survival of participants in the prostate cancer prevention trial. N Engl J Med 369:603–610
Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML (2011) Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients. J Sex Med 8:872–884
Tackling Side Effects: Nocebo Effect
Kennedy WP (1961) The nocebo reaction. Med World 95:203–205
Mondaini N, Gontero P, Giubilei G, Lombardi G, Cai T, Gavazzi A, Bartoletti R (2007) Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? J Sex Med 4:1708–1712
Tackling Side Effects: Post-finasteride Syndrome
Irwig MS (2012) Persistent sexual side effects of finasteride: could they be permanent? J Sex Med 9:2927–2932
LeFevre M (2013) A role for finasteride in the prevention of prostate cancer? N Engl J Med 369:670–671
Cosmetic Camouflage and Hair Prosthesis
Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J (2008) Interventions for alopecia areata. Cochrane Database Syst Rev (2):CD004413
Draelos ZD (2013) Shampoos, conditioners, and camouflage techniques. Dermatol Clin 31:173–178
Vandegrift KV (1994) The development of an oncology alopecia wig program. J Intraven Nurs 17:78–82
van der Velden EM et al (1998) Dermatography as a new treatment for alopecia areata of the eyebrows. Int J Dermatol 37:617–621
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Trüeb, R.M., Lee, WS. (2014). Patient Expectation Management. In: Male Alopecia. Springer, Cham. https://doi.org/10.1007/978-3-319-03233-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-03233-7_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-03232-0
Online ISBN: 978-3-319-03233-7
eBook Packages: MedicineMedicine (R0)